Horizon Pharma plc to Present at the 36th Annual J.P. Morgan Healthcare Conference

DUBLIN, Ireland, Dec. 18, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it plans to present at the 36^th Annual J.P. Morgan Healthcare Conference.  Timothy P. Walbert, chairman, president and chief executive officer, will present at 11 a.m. PT on Jan. 9, 2018. 

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:
Tina Ventura
Senior Vice President,
Investor Relations
[email protected]

Ruth Venning
Executive Director,
Investor Relations
[email protected]

U.S. Media:
Geoff Curtis
Senior Vice President, 
Corporate Affairs & Chief Communications Officer
[email protected]

Ireland Media:
Ray Gordon
Gordon MRM
[email protected]